MedRhythms Welcomes Larry Jasinski as Chief Executive Officer to Drive Next Stage of Growth and Commercial Expansion,PR Newswire Healthring


MedRhythms Welcomes Larry Jasinski as Chief Executive Officer to Drive Next Stage of Growth and Commercial Expansion

Boston, MA – July 7, 2025 – MedRhythms, a pioneering digital therapeutics company focused on leveraging music to improve neurological function and rehabilitation, is pleased to announce the appointment of Larry Jasinski as its new Chief Executive Officer, effective immediately. Mr. Jasinski brings a wealth of experience and a proven track record of success in leading and scaling innovative healthcare and technology companies. His leadership is expected to usher in a new era of growth and commercial expansion for MedRhythms.

This significant appointment comes at a pivotal moment for MedRhythms, as the company continues to advance its groundbreaking digital therapeutics in neuroscience. The selection of Mr. Jasinski underscores MedRhythms’ commitment to strategically positioning itself for widespread adoption and impact within the healthcare landscape.

Mr. Jasinski is a highly respected figure in the healthcare industry, renowned for his strategic vision and operational expertise. Throughout his career, he has demonstrated a consistent ability to navigate complex markets, drive product innovation, and build high-performing teams. His experience includes successfully guiding companies through critical growth phases, including commercialization and market penetration.

“We are incredibly excited to welcome Larry Jasinski to MedRhythms,” said the MedRhythms Board of Directors in a joint statement. “Larry’s deep understanding of the digital health sector and his proven leadership in scaling innovative companies make him the ideal choice to lead MedRhythms into its next chapter. His vision and strategic acumen will be instrumental as we accelerate our commercial efforts and expand access to our transformative music-based therapies for patients worldwide.”

MedRhythms’ innovative approach utilizes rhythm and music as therapeutic interventions to address a range of neurological conditions, including stroke, Parkinson’s disease, and traumatic brain injury. The company’s technology is designed to promote neuroplasticity, improve motor control, and enhance cognitive function, offering a novel and engaging pathway to recovery and improved quality of life for patients.

Under Mr. Jasinski’s leadership, MedRhythms aims to further solidify its position as a leader in the rapidly evolving field of digital therapeutics. Key priorities will include expanding the company’s product pipeline, forging strategic partnerships with healthcare providers and payers, and driving broader patient access to its evidence-based solutions.

“I am honored to join MedRhythms at such an exciting time,” said Larry Jasinski. “The potential of music and rhythm to revolutionize neurological rehabilitation is profound, and MedRhythms is at the forefront of this innovation. I am deeply impressed by the company’s scientific foundation, the dedication of its team, and the tangible positive impact its therapies are having on patients’ lives. I look forward to working with the team to accelerate our mission, bring these vital therapies to more individuals, and achieve significant commercial growth.”

The appointment of Mr. Jasinski is anticipated to bring renewed momentum to MedRhythms, enabling the company to capitalize on the growing demand for effective and accessible digital health solutions. His leadership is expected to be a key driver in achieving the company’s ambitious goals and advancing its mission to transform neurological care through the power of music.

About MedRhythms: MedRhythms is a digital therapeutics company that uses music and rhythm to improve neurological function and rehabilitation. By leveraging the brain’s natural response to music, MedRhythms develops evidence-based digital therapeutics that promote neuroplasticity, enhance motor control, and improve cognitive outcomes for patients with neurological conditions. The company is dedicated to advancing the science and accessibility of music-based interventions in healthcare.


MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion


AI has delivered the news.

The answer to the following question is obtained from Google Gemini.


PR Newswire Healthring published ‘MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion’ at 2025-07-07 15:00. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.

Leave a Comment